オピオイド耐性 - 聖杯を求めて
Brigitte L Kieffer1, Christopher J Evans
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67400 Illkirch, France. briki@igbmc.u-strasbg.fr
Cell
|March 15, 2002
まとめ
痛み止めに対する一般的な適応であるオピオイド耐性は,受容体内化によって低下し,受容体無感化に関する伝統的な見解に異議を唱える可能性があります. この発見は,疼痛治療の管理に関する新しい洞察を提供します.
科学分野:
- 薬理学 薬理学とは
- 神経科学は神経科学である.
- 細胞生物学 細胞生物学
背景:
- オピオイド耐性は,慢性疼痛の管理における重要な課題です.
- 伝統的に,オピオイド耐性は,オピオイド受容体の無敏感化と細胞表面受容体の発現の減少に起因する.
- 最近の研究では,代替メカニズムが関与している可能性があることを示唆しています.
研究 の 目的:
- オピオイド受容体内化がオピオイド耐性の発達における役割を調査する.
- オピオイド耐性メカニズムの確立された理解に挑戦する.
主な方法:
- この研究では,受容体の行動を観察する実験をvivoで実施した可能性が高い.
- 方法は,受容体シグナル伝達と細胞表面表現を測定する技術を含むことができる.
- 長期にわたるオピオイド治療に対する行動適応の分析.
主要な成果:
- 証拠は,受容体内化がオピオイド耐性を低下させる可能性があることを示唆しています.
- これは,受容体無感化に関する従来の説明と対照的である.
結論:
- オピオイド受容体の内部化は,耐性の発達に対する保護的メカニズムである可能性があります.
- この発見は,オピオイド耐性の基礎となるメカニズムの再評価を必要とします.
さらに関連する動画
関連する概念動画
Desensitization and Tachyphylaxis
3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K
Drug Abuse and Addiction: Pharmacological Phenomena
1.7K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.7K
Opioid Receptors: Overview
7.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.4K
Analgesia and Pain Management
3.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.4K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.7K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.6K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.6K


